(PAHC) on Wednesday reported fiscal fourth-quarter earnings of $21.7 million. The Teaneck, New Jersey-based company said it had profit of 53 cents per share. Earnings, adjusted for non-recurring costs and costs related to mergers and acquisitions, were 85 cents per share.
The results exceeded Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for earnings of 72 cents per share. The maker of animal health products and nutritional supplements posted revenue of $396.7 million in the period, also exceeding Street forecasts.
Three analysts surveyed by Zacks expected $366.1 million. For the year, the company reported profit of $99.7 million, or $2.43 per share. Revenue was reported as $1.52 billion.
Phibro expects full-year revenue in the range of $1.55 billion to $1.6 billion. _____ This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PAHC at https://www.zacks.com/ap/PAHC Source
(NVDA) on Wednesday reported fiscal second-quarter net income of $59.69 billion. On a per-share basis, the Santa Clara, California-based company said it had profit of $2.46. Earnings, adjusted for non-recurring gains, were $2.22 per share.
The results topped Wall Street expectations. The average estimate of 12 analysts surveyed by Zacks Investment Research was for earnings of $2.09 per share. The maker of graphics chips for gaming and artificial intelligence posted revenue of $96.22 billion in the period, also surpassing Street forecasts.
Summary from source